We Need a Global System for Testing and Approving Cancer Treatments

The United States has already made significant progress in setting up an international regulatory infrastructure for the simultaneous review and potential approvals of new cancer treatments with Project Orbis, an initiative of the Food and Drug Administration (FDA) Oncology Center of Excellence. The task ahead is to take that framework and further internationalize it.

Read via Harvard Business Review here.